Longeveron, Inc. (LGVN)
0.535
0.00 (0.00%)
USD |
NASDAQ |
Jan 21, 12:35
Longeveron Market Cap: 11.41M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 16.39M |
| AIM ImmunoTech, Inc. | 3.412M |
| IGC Pharma, Inc. | 26.33M |
| NovaBay Pharmaceuticals, Inc. | 725.50M |
| Protalix Biotherapeutics, Inc. | 159.64M |
Market Cap Related Metrics
| PS Ratio | 5.885 |
| Price to Book Value | 1.145 |
| Price | 0.535 |
| Earnings Yield | -249.9% |